New York, United States
For more than 20 years, we have made global investments in the healthcare sector, covering a broad spectrum ranging from fledgling private establishments to big international enterprises. Our workforce consists of over 100 eminent industry personnel with expertise in scientific research, medical affairs, financial investment and other fields, who collectively manage over $17 billion in public and private company investments across the globe.
437
Total Investments
277
Portfolio Companies
-
Exits
2
Industries
General Information
Industries
Financial Services, Health Care
Funding Stage
Series A +2
Company Overview
Investment Criteria
Investment Thesis
•••••• •••••• ••••••
About OrbiMed
Recent Investments (437)
View All| Company | Stage | Amount | Date |
|---|---|---|---|
| Private Placement Vc | •••••• | Jun 2026 | |
| Series C | •••••• | Apr 2026 | |
| Early VC | •••••• | Mar 2026 | |
| Series B | •••••• | Mar 2026 | |
| Post Ipo Equity | •••••• | Jan 2026 | |
•••• ••••
|
Series B | •••••• | Jan 2026 |
|
•••• ••••
|
Series C | •••••• | Nov 2025 |
|
•••• ••••
|
Post Ipo Equity | •••••• | Nov 2025 |
|
•••• ••••
|
Early VC | •••••• | Sep 2025 |
|
•••• ••••
|
Series B | •••••• | Sep 2025 |
Latest News
All startup & investor data, one platform.
Filter investors by stage, sector, and geography. Compare portfolios side by side. Spot market signals before anyone else.
